Literature DB >> 2413034

Monoclonal antibodies against rat brain hexokinase. Utilization in epitope mapping studies and establishment of structure-function relationships.

J E Wilson, A D Smith.   

Abstract

The effects of seven monoclonal antibodies on various functions of rat brain hexokinase (ATP:D-hexose-6-phosphotransferase, EC 2.7.1.1) have been assessed. Specifically, effects on catalytic properties (Km values for substrates, glucose and ATP X Mg2+; Ki for inhibition by glucose 6-phosphate), binding to the outer mitochondrial membrane, and glucose 6-phosphate-induced solubilization of mitochondrially bound hexokinase were examined. Epitope mapping studies with the native enzyme provided information about the relative spatial distribution of the epitopes on the surface of the native molecule. Binding of nucleotides (ATP or ATP X Mg2+) was shown to perturb the epitopes recognized by two of these antibodies. Neither nucleotides nor other ligands (glucose, glucose 6-phosphate, Pi) had detectable effect on epitopes recognized by the other five antibodies. Peptide mapping techniques in conjunction with immunoblotting permitted assignment of the epitopes recognized by several of the antibodies to specific segments within the overall primary structure. These results, together with previous work relating to the organization of structural domains within the molecule, permitted development of a three-dimensional model which provides a useful representation of major structural and immunological features of the enzyme, and depicts the association of those features with specific functions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413034

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Binding of rat brain hexokinase to recombinant yeast mitochondria: identification of necessary molecular determinants.

Authors:  H Azoulay-Zohar; C Aflalo
Journal:  J Bioenerg Biomembr       Date:  1999-12       Impact factor: 2.945

2.  Hexokinase 'binding sites' of normal and tumoral human brain mitochondria.

Authors:  A Golestani; M Nemat-Gorgani
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

Review 3.  Hexokinase-binding properties of the mitochondrial VDAC protein: inhibition by DCCD and location of putative DCCD-binding sites.

Authors:  R A Nakashima
Journal:  J Bioenerg Biomembr       Date:  1989-08       Impact factor: 2.945

4.  Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line.

Authors:  L Miccoli; S Oudard; F Sureau; F Poirson; B Dutrillaux; M F Poupon
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

5.  RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.

Authors:  Azamat Aslanukov; Reshma Bhowmick; Mallikarjuna Guruju; John Oswald; Dorit Raz; Ronald A Bush; Paul A Sieving; Xinrong Lu; Cheryl B Bock; Paulo A Ferreira
Journal:  PLoS Genet       Date:  2006-09-01       Impact factor: 5.917

6.  Modulation of hexokinase association with mitochondria analyzed with quantitative three-dimensional confocal microscopy.

Authors:  R M Lynch; K E Fogarty; F S Fay
Journal:  J Cell Biol       Date:  1991-02       Impact factor: 10.539

7.  Identification of a mitochondrial-binding site on the N-terminal end of hexokinase II.

Authors:  Nadezda Bryan; Kevin P Raisch
Journal:  Biosci Rep       Date:  2015-04-24       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.